| dbo:abstract |
Novo Holdings A/S ist ein dänischer Pharmahersteller; zu der Novo-Gruppe gehören die eigenständigen agierenden Tochterunternehmen Novo Nordisk, Novozymes und .Die Novo Holdings gehört der Novo Nordisk Foundation und ist Hauptanteilseigner der drei Pharmaunternehmen. Sitz der Novo Holdings ist Hellerup in Dänemark. Die Novo Holdings managt das Vermögen der Novo-Gruppe, rund 300 Milliarden DKK. (de) Novo Holdings A/S (formerly Novo A/S) is the Novo Nordisk Foundation's wholly owned holding company for Novo Nordisk A/S and Novozymes A/S. Novo Holdings A/S was established in 1999 and manages the Novo Nordisk Foundation’s assets, which in 2021 was worth almost DKK 700 billion Danish Kroner (approximately US$93.73 billion) and is the largest charitable foundation in the world making Novo Holdings A/S a world-leading life sciences investor. Novo Holdings A/S is headquartered in Copenhagen, Denmark, with offices in San Francisco, Boston and Singapore. Eivind Kolding succeeded Henrik Gürtler as CEO on 1 May 2014. Eivind Kolding left Novo Holdings A/S in March 2016 and Kasim Kutay took over as CEO for the organisation. Since 2016 Kasim Kutay has been the CEO of Novo Holdings A/S. (en) |
| dbo:assets |
6.97E11 (dbd:danishKrone) 9.373E10 (dbd:usDollar) |
| dbo:foundingYear |
1999-01-01 (xsd:gYear) |
| dbo:keyPerson |
dbr:Lars_Rebien_Sørensen dbr:Kasim_Kutay |
| dbo:subsidiary |
dbr:Novozymes dbr:Novo_Nordisk_A/S |
| dbo:thumbnail |
wiki-commons:Special:FilePath/Novo_Holdings_logo.svg?width=300 |
| dbo:wikiPageExternalLink |
https://www.novoholdings.dk https://web.archive.org/web/20140705023011/http:/www.novo.dk/ |
| dbo:wikiPageID |
43319645 (xsd:integer) |
| dbo:wikiPageLength |
26464 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID |
1123132760 (xsd:integer) |
| dbo:wikiPageWikiLink |
dbr:San_Francisco dbr:Enterprise_foundation dbr:Boston dbr:Denmark dbr:Mergers_and_acquisitions dbr:Leveraged_buyout dbr:Convatec dbr:Copenhagen dbr:Chief_executive_officer dbr:Chr._Hansen dbr:Eivind_Kolding dbr:Moelis_&_Company dbr:Morgan_Stanley dbc:Companies_based_in_Gentofte_Municipality dbr:Singapore dbr:Steen_Riisgaard dbr:Hellerup dbr:CEO dbr:Lars_Rebien_Sørensen dbr:Danish_krone dbr:Danske_Bank dbr:Novo_Nordisk dbr:Novo_Nordisk_Foundation dbr:Novozymes dbr:The_Carlyle_Group dbr:Chairman dbr:Kasim_Kutay dbr:Biotechnology dbr:Biotechnology_in_pharmaceutical_manufacturing dbr:Henrik_Poulsen dbr:Recapitalization dbc:Holding_companies_of_Denmark dbr:Humanitarianism dbr:List_of_wealthiest_charitable_foundations dbr:Philanthropy dbr:Xellia dbr:Secondary_buyout dbr:Novo_Nordisk_A/S dbr:Sonion |
| dbp:assets |
(Approx. $93.73 billion ) (en) 6.97E11 (dbd:danishKrone) |
| dbp:foundation |
1999 (xsd:integer) |
| dbp:homepage |
https://www.novoholdings.dk |
| dbp:industry |
Asset management (en) Life Sciences (en) |
| dbp:keyPeople |
Lars Rebien Sørensen (en) Kasim Kutay (en) |
| dbp:locationCity |
dbr:Hellerup |
| dbp:locationCountry |
dbr:Denmark |
| dbp:logo |
Novo Holdings logo.svg (en) |
| dbp:name |
Novo Holdings A/S (en) |
| dbp:services |
Investments in Life Science (en) |
| dbp:subsid |
dbr:Novozymes dbr:Novo_Nordisk_A/S (en) |
| dbp:type |
Private limited company (en) |
| dbp:wikiPageUsesTemplate |
dbt:Authority_control dbt:Infobox_company dbt:Official dbt:Reflist dbt:Short_description |
| dct:subject |
dbc:Companies_based_in_Gentofte_Municipality dbc:Holding_companies_of_Denmark |
| rdf:type |
owl:Thing dbo:Company schema:Organization dul:Agent dul:SocialPerson dbo:Agent wikidata:Q24229398 wikidata:Q43229 wikidata:Q4830453 dbo:Organisation |
| rdfs:comment |
Novo Holdings A/S ist ein dänischer Pharmahersteller; zu der Novo-Gruppe gehören die eigenständigen agierenden Tochterunternehmen Novo Nordisk, Novozymes und .Die Novo Holdings gehört der Novo Nordisk Foundation und ist Hauptanteilseigner der drei Pharmaunternehmen. Sitz der Novo Holdings ist Hellerup in Dänemark. Die Novo Holdings managt das Vermögen der Novo-Gruppe, rund 300 Milliarden DKK. (de) Novo Holdings A/S (formerly Novo A/S) is the Novo Nordisk Foundation's wholly owned holding company for Novo Nordisk A/S and Novozymes A/S. Novo Holdings A/S was established in 1999 and manages the Novo Nordisk Foundation’s assets, which in 2021 was worth almost DKK 700 billion Danish Kroner (approximately US$93.73 billion) and is the largest charitable foundation in the world making Novo Holdings A/S a world-leading life sciences investor. Novo Holdings A/S is headquartered in Copenhagen, Denmark, with offices in San Francisco, Boston and Singapore. (en) |
| rdfs:label |
Novo Holdings (de) Novo Holdings A/S (en) |
| owl:sameAs |
wikidata:Novo Holdings A/S dbpedia-da:Novo Holdings A/S dbpedia-de:Novo Holdings A/S dbpedia-fa:Novo Holdings A/S dbpedia-no:Novo Holdings A/S https://global.dbpedia.org/id/i9JQ |
| prov:wasDerivedFrom |
wikipedia-en:Novo_Holdings_A/S?oldid=1123132760&ns=0 |
| foaf:depiction |
wiki-commons:Special:FilePath/Novo_Holdings_logo.svg |
| foaf:homepage |
https://www.novoholdings.dk |
| foaf:isPrimaryTopicOf |
wikipedia-en:Novo_Holdings_A/S |
| foaf:name |
Novo Holdings A/S (en) |
| is dbo:employer of |
dbr:Kasim_Kutay |
| is dbo:parentCompany of |
dbr:Novozymes |
| is dbo:wikiPageRedirects of |
dbr:Novo_A/S |
| is dbo:wikiPageWikiLink of |
dbr:List_of_largest_biomedical_companies_by_market_capitalization dbr:Novo_A/S dbr:Lars_Rebien_Sørensen dbr:List_of_British_Turks dbr:Novo_Nordisk dbr:Novo_Nordisk_Foundation dbr:Novozymes dbr:Oxford_Biomedica dbr:Kasim_Kutay dbr:Synlab_Group |
| is dbp:employer of |
dbr:Kasim_Kutay |
| is dbp:parent of |
dbr:Novozymes |
| is foaf:primaryTopic of |
wikipedia-en:Novo_Holdings_A/S |
